TABLE 2. Trends in vaccination coverage* with ≥1 dose measles, mumps, and rubella vaccine,^† rotavirus vaccine,^§ and the combined 7-vaccine series^¶ among children eligible** for the Vaccines for Children program and difference in coverage between program-eligible and nonprogram-eligible children born during 2011–2020 — National Immunization Survey-Child, United States, 2012–2022.

Birth year	Vaccine measure
	MMR† (≥1 dose)		Rotavirus§ (received by age 8 mos, 0 days)		Combined 7-vaccine series¶
	Coverage % (95% CI)	Percentage point difference (95% CI)	Coverage % (95% CI)	Percentage point difference (95% CI)	Coverage % (95% CI)	Percentage point difference (95% CI)
2011	88.8 (87.1 to 90.4)	–2.8 (–4.9 to –0.7)††	64.8 (62.3 to 67.1)	–13.0 (–16.0 to –10.0)††	63.5 (61.1 to 65.9)	–9.1 (–12.2 to –5.9)††
2012	88.9 (87.4 to 90.2)	–3.7 (–5.4 to –2.0)††	65.8 (63.5 to 67.9)	–12.0 (–15.0 to –9.1)††	65.3 (63.0 to 67.5)	–8.1 (–11.1 to –5.0)††
2013	88.8 (87.3 to 90.2)	–3.2 (–5.1 to –1.2)††	67.0 (64.8 to 69.2)	–11.9 (–14.6 to –9.1)††	64.5 (62.2 to 66.7)	–8.2 (–11.2 to –5.3)††
2014	88.0 (86.2 to 89.7)	–4.1 (–6.3 to –1.8)††	66.0 (63.5 to 68.4)	–13.6 (–16.8 to –10.4)††	64.0 (61.6 to 66.4)	–8.8 (–12.2 to –5.4)††
2015	88.3 (86.8 to 89.8)	–4.7 (–6.5 to –2.9)††	66.1 (63.6 to 68.6)	–13.5 (–16.7 to –10.3)††	64.2 (61.7 to 66.7)	–9.1 (–12.3 to –5.8)††
2016	88.9 (87.2 to 90.4)	–3.9 (–5.8 to –2.0)††	67.7 (65.1 to 70.2)	–14.9 (–17.9 to –11.9)††	64.0 (61.4 to 66.7)	–11.4 (–14.7 to –8.1)††
2017	88.0 (86.5 to 89.5)	–4.8 (–6.8 to –2.7)††	65.7 (63.5 to 67.8)	–17.1 (–19.7 to –14.4)††	64.3 (62.1 to 66.6)	–11.3 (–14.2 to –8.4)††
2018	89.9 (88.5 to 91.2)	–4.8 (–6.4 to –3.3)††	71.1 (69.1 to 73.0)	–12.8 (–15.2 to –10.4)††	63.5 (61.4 to 65.6)	–13.5 (–16.2 to –10.9)††
2019	89.0 (87.6 to 90.4)	–5.5 (–7.2 to –3.9)††	70.5 (68.5 to 72.5)	–12.9 (–15.4 to –10.5)††	65.0 (62.8 to 67.2)	–10.6 (–13.3 to –7.8)††
2020§§	89.6 (87.7 to 91.3)	–3.8 (–6.0 to –1.6)††	71.0 (68.3 to 73.5)	–11.5 (–14.8 to –8.3)††	61.4 (58.4 to 64.4)	–13.8 (–17.6 to –10.0)††
AAPPC¶¶	0.1 (–0.1 to 0.2)	–0.2 (–0.4 to –0.1)***	0.7 (0.3 to 1.1)***	–0.1 (–0.5 to 0.4)	–0.1 (–0.3 to 0.1)	–0.6 (–0.9 to –0.3)***

Abbreviations: AAPPC = average annual percentage point change in coverage; AI/AN = American Indian or Alaska Native; MMR = measles, mumps, and rubella vaccine; VFC = Vaccines for Children.

* Coverage with ≥1 dose MMR and the combined 7-vaccine series were assessed by age 24 months (before the day the child turns 24 months). Rotavirus vaccine series was assessed by age 8 months, 0 days. The Kaplan-Meier method was used to estimate vaccination coverage to account for children whose vaccination history was ascertained before age 24 months.

^† Includes children who might have received measles, mumps, rubella, and varicella combination vaccine.

^§ Two or more doses of Rotarix monovalent rotavirus vaccine, or ≥3 doses of RotaTeq pentavalent rotavirus vaccine. (If any dose in the series is either RotaTeq or unknown, it was assumed a 3-dose series was needed. The maximum age for receipt of the final rotavirus vaccine dose is 8 months, 0 days.

^¶ The combined 7-vaccine series (4:3:1:3*:3:1:4) includes ≥4 doses of diphtheria and tetanus toxoids and acellular pertussis vaccine, ≥3 doses of poliovirus vaccine, ≥1 dose of measles-containing vaccine, the full series of Haemophilus influenzae type b conjugate vaccine (≥3 or ≥4 doses, depending on product type), ≥3 doses of hepatitis B vaccine, ≥1 dose of varicella vaccine, and ≥4 doses of pneumococcal conjugate vaccine.

** Child is identified as AI/AN; insured by Medicaid or Indian Health Service; uninsured; or received at least one vaccine at an Indian Health Service–operated center, Tribal health facility, or urban Indian health care facility.

^†† Statistically significant (p<0.05) percentage point difference in coverage (VFC-eligible − non–VFC-eligible).

^§§ Data for the 2020 birth year are considered preliminary and are from survey years 2021 and 2022. Data from survey year 2023 were not available in time to include in this report.

^¶¶ Slope of line created by fitting a linear regression model to the coverage estimates from birth years 2011–2020.

*** AAPPC is statistically significantly different from zero (p<0.05).